Citation Relationships

Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S (2019) A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. Front Neural Circuits 13:11 [PubMed]

   Excitotoxic loss of dopaminergic cells in PD (Muddapu et al 2019)

References and models cited by this paper

References and models that cite this paper

Adhihetty PJ, Beal MF (2008) Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular Med 10:275-90 [Journal] [PubMed]

Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42:733-8 [PubMed]

Allers KA,Walters JR,Kreiss DS (2003) euronal firing patterns in the subthalamic nucleus The Basal Ganglia, Graybiel AM:Delong MR:Kitai ST, ed. pp.245

Alvarez L, Macias R, Pavón N, López G, Rodríguez-Oroz MC, Rodríguez R, Alvarez M, Pedroso I, Teijeiro J, Fernández R, Casabona E, Salazar S, Maragoto C, Carballo M, García I, Guridi J, Juncos JL, DeLong MR, Obeso JA (2009) Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry 80:979-85 [Journal] [PubMed]

Ambrosi G, Cerri S, Blandini F (2014) A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease. J Neural Transm (Vienna) 121:849-59 [Journal] [PubMed]

Ammari R, Bioulac B, Garcia L, Hammond C (2011) The Subthalamic Nucleus becomes a Generator of Bursts in the Dopamine-Depleted State. Its High Frequency Stimulation Dramatically Weakens Transmission to the Globus Pallidus. Front Syst Neurosci 5:43 [Journal] [PubMed]

Anselmi L, Bove C, Coleman FH, Le K, Subramanian MP, Venkiteswaran K, Subramanian T, Travagli RA (2018) Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. NPJ Parkinsons Dis 4:30 [Journal] [PubMed]

Armentero MT, Fancellu R, Nappi G, Bramanti P, Blandini F (2006) Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol Dis 22:1-9 [Journal] [PubMed]

Austin PJ, Betts MJ, Broadstock M, O'Neill MJ, Mitchell SN, Duty S (2010) Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease. Br J Pharmacol 160:1741-53 [Journal] [PubMed]

Battaglia G, Busceti CL, Pontarelli F, Biagioni F, Fornai F, Paparelli A, Bruno V, Ruggieri S, Nicoletti F (2003) Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Neuropharmacology 45:155-66 [PubMed]

Beal MF, Hyman BT, Koroshetz W (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16:125-31 [PubMed]

Benazzouz A, Piallat B, Ni ZG, Koudsie A, Pollak P, Benabid AL (2000) Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease. Cell Transplant 9:215-21 [PubMed]

Bergman H, Feingold A, Nini A, Raz A, Slovin H, Abeles M, Vaadia E (1998) Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci 21:32-8 [PubMed]

Bergman H, Wichmann T, Karmon B, DeLong MR (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72:507-20 [Journal] [PubMed]

Betts MJ, O'Neill MJ, Duty S (2012) Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease. Br J Pharmacol 166:2317-30 [Journal] [PubMed]

Beurrier C, Congar P, Bioulac B, Hammond C (1999) Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. J Neurosci 19:599-609 [PubMed]

Bezard E, Boraud T, Bioulac B, Gross CE (1999) Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. Eur J Neurosci 11:2167-70 [PubMed]

Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 21:6853-61 [PubMed]

Bezard E, Gross CE, Brotchie JM (2003) Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 26:215-21 [Journal] [PubMed]

Blandini F (2001) The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease. Funct Neurol 16:99-106 [PubMed]

Blandini F (2010) An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease. Funct Neurol 25:65-71 [PubMed]

Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 27:1478-83 [Journal] [PubMed]

Booth HDE, Hirst WD, Wade-Martins R (2017) The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis. Trends Neurosci 40:358-370 [Journal] [PubMed]

Brouillet E, Beal MF (1993) NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuroreport 4:387-90 [PubMed]

Brown P (2003) Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 18:357-63 [Journal] [PubMed]

Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro V (2001) Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 21:1033-8 [PubMed]

Carron R, Chaillet A, Filipchuk A, Pasillas-Lépine W, Hammond C (2013) Closing the loop of deep brain stimulation. Front Syst Neurosci 7:112 [Journal] [PubMed]

Carvalho GA, Nikkhah G (2001) Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 171:405-17 [Journal] [PubMed]

Chakravarthy VS,Moustafa AA (2018) Computational Neuroscience Models of the Basal Ganglia Cognitive Science and Technology.

Chan H, Paur H, Vernon AC, Zabarsky V, Datla KP, Croucher MJ, Dexter DT (2010) Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease. Parkinsons Dis [Journal] [PubMed]

Chander BS, Chakravarthy VS (2012) A computational model of neuro-glio-vascular loop interactions. PLoS One 7:e48802 [Journal] [PubMed]

Chen L, Liu Z, Tian Z, Wang Y, Li S (2000) Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions. Stereotact Funct Neurosurg 75:66-75 [Journal] [PubMed]

Chhabria K, Chakravarthy VS (2016) Low-Dimensional Models of "Neuro-Glio-Vascular Unit" for Describing Neural Dynamics under Normal and Energy-Starved Conditions. Front Neurol 7:24 [Journal] [PubMed]

Chiken S, Nambu A (2016) Mechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption? Neuroscientist 22:313-22 [Journal] [PubMed]

Chiti F, Dobson CM (2017) Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem 86:27-68 [Journal] [PubMed]

Cogan SF (2008) Neural stimulation and recording electrodes. Annu Rev Biomed Eng 10:275-309 [Journal] [PubMed]

Courtney NA, Mamaligas AA, Ford CP (2012) Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing. J Neurosci 32:13520-8 [Journal] [PubMed]

Cragg SJ, Baufreton J, Xue Y, Bolam JP, Bevan MD (2004) Synaptic release of dopamine in the subthalamic nucleus. Eur J Neurosci 20:1788-802 [Journal] [PubMed]

Cullen M, Wong-Lin K (2015) Integrated dopaminergic neuronal model with reduced intracellular processes and inhibitory autoreceptors. IET Syst Biol 9:245-58 [Journal] [PubMed]

Dayan P, Abbott LF (2005) Theoretical neuroscience: computational and mathematical modeling of neural systems :24-27

Dovzhenok A, Rubchinsky LL (2012) On the origin of tremor in Parkinson's disease. PLoS One 7:e41598 [Journal] [PubMed]

Ebert M, Hauptmann C, Tass PA (2014) Coordinated reset stimulation in a large-scale model of the STN-GPe circuit. Front Comput Neurosci 8:154 [Journal] [PubMed]

Fan KY, Baufreton J, Surmeier DJ, Chan CS, Bevan MD (2012) Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. J Neurosci 32:13718-28 [Journal] [PubMed]

Fenoy AJ, Goetz L, Chabardès S, Xia Y (2014) Deep brain stimulation: are astrocytes a key driver behind the scene? CNS Neurosci Ther 20:191-201 [Journal] [PubMed]

Ferrigno A, Vairetti M, Ambrosi G, Rizzo V, Richelmi P, Blandini F, Fuzzati-Armentero MT (2015) Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats. Clin Exp Pharmacol Physiol 42:695-703 [Journal] [PubMed]

Ford CP (2014) The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282:13-22 [Journal] [PubMed]

Foutz TJ, McIntyre CC (2010) Evaluation of novel stimulus waveforms for deep brain stimulation. J Neural Eng 7:066008 [Journal] [PubMed]

Fuzzati-Armentero MT, Cerri S, Levandis G, Ambrosi G, Montepeloso E, Antoninetti G, Blandini F, Baqi Y, Müller CE, Volpini R, Costa G, Simola N, Pinna A (2015) Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease. J Neurochem 134:740-7 [Journal] [PubMed]

Gandrakota R, Chakravarthy VS, Pradhan RK (2010) A model of indispensability of a large glial layer in cerebrovascular circulation. Neural Comput 22:949-68 [Journal] [PubMed]

Gao J, Wang L, Liu J, Xie F, Su B, Wang X (2017) Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases. Antioxidants (Basel) [Journal] [PubMed]

Garcia L, D'Alessandro G, Bioulac B, Hammond C (2005) High-frequency stimulation in Parkinson's disease: more or less? Trends Neurosci 28:209-16 [Journal] [PubMed]

German DC, Manaye KF, Sonsalla PK, Brooks BA (1992) Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci 648:42-62 [PubMed]

Giguère N, Burke Nanni S, Trudeau LE (2018) On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. Front Neurol 9:455 [Journal] [PubMed]

Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918-34 [Journal] [PubMed]

Golomb D (2007) Neuronal synchrony measures Scholarpedia 2:1347

Götz T, Kraushaar U, Geiger J, Lübke J, Berger T, Jonas P (1997) Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J Neurosci 17:204-15 [PubMed]

Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization. Neuroscience 10:301-15 [PubMed]

Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4:2866-76 [PubMed]

Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-90 [PubMed]

Grandas F (2000) The putative neuroprotective role of dopamine agonists in Parkinson's disease. Neurotox Res 2:205-13 [PubMed]

Greene JG, Greenamyre JT (1996) Bioenergetics and glutamate excitotoxicity. Prog Neurobiol 48:613-34 [PubMed]

Guridi J, Marigil M, Becerra V, Parras O (2016) [Neuroprotective subthalamotomy in Parkinson's disease. The role of magnetic resonance-guided focused ultrasound in early surgery]. Neurocirugia (Astur) 27:285-290 [Journal] [PubMed]

Guridi J, Obeso JA (2015) Letter to the editor: Parkinson's disease and early subthalamotomy. J Neurosurg 122:980-1 [Journal] [PubMed]

Hamani C, Florence G, Heinsen H, Plantinga BR, Temel Y, Uludag K, Alho E, Teixeira MJ, Amaro E, Fonoff ET (2017) Subthalamic Nucleus Deep Brain Stimulation: Basic Concepts and Novel Perspectives. eNeuro [Journal] [PubMed]

Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM (2004) The subthalamic nucleus in the context of movement disorders. Brain 127:4-20 [Journal] [PubMed]

Hammond C, Ammari R, Bioulac B, Garcia L (2008) Latest view on the mechanism of action of deep brain stimulation. Mov Disord 23:2111-21 [Journal] [PubMed]

Hansel D, Mato G, Meunier C (1995) Synchrony in excitatory neural networks. Neural Comput 7:307-37 [PubMed]

Hassani OK, François C, Yelnik J, Féger J (1997) Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res 749:88-94 [PubMed]

Hasselmo ME (1994) Runaway synaptic modification in models of cortex: implications for Alzheimers disease Neural Networks 7:13-40

Hasselmo ME (1997) A computational model of the progression of Alzheimer's disease. MD Comput 14:181-91 [PubMed]

Hauptmann C, Tass PA (2007) Therapeutic rewiring by means of desynchronizing brain stimulation. Biosystems 89:173-81 [Journal] [PubMed]

Hebb MO, Robertson HA (2000) Identification of a subpopulation of substantia nigra pars compacta gamma-aminobutyric acid neurons that is regulated by basal ganglia activity. J Comp Neurol 416:30-44 [PubMed]

Hegeman DJ, Hong ES, Hernández VM, Chan CS (2016) The external globus pallidus: progress and perspectives. Eur J Neurosci 43:1239-65 [Journal] [PubMed]

Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4:600-9 [Journal] [PubMed]

Hofmann L, Ebert M, Tass PA, Hauptmann C (2011) Modified pulse shapes for effective neural stimulation. Front Neuroeng 4:9 [Journal] [PubMed]

Hsieh MH, Ho SC, Yeh KY, Pawlak CR, Chang HM, Ho YJ, Lai TJ, Wu FY (2012) Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model. Pharmacol Biochem Behav 102:64-71 [Journal] [PubMed]

Humphries MD, Stewart RD, Gurney KN (2006) A physiologically plausible model of action selection and oscillatory activity in the basal ganglia. J Neurosci 26:12921-42 [Journal] [PubMed]

   Spiking neuron model of the basal ganglia (Humphries et al 2006) [Model]

Hwang O (2013) Role of oxidative stress in Parkinson's disease. Exp Neurobiol 22:11-7 [Journal] [PubMed]

Iglesias J, Villa AE (2008) Emergence of preferred firing sequences in large spiking neural networks during simulated neuronal development. Int J Neural Syst 18:267-77 [Journal] [PubMed]

Izhikevich E (2006) Bursting Scholarpedia :16824

Izhikevich EM (2003) Simple model of spiking neurons. IEEE Trans Neural Netw 14:1569-72 [Journal] [PubMed]

   Artificial neuron model (Izhikevich 2003, 2004, 2007) [Model]

Jahr CE, Stevens CF (1990) Voltage dependence of NMDA-activated macroscopic conductances predicted by single-channel kinetics. J Neurosci 10:3178-82 [PubMed]

Jang JY, Jang M, Kim SH, Um KB, Kang YK, Kim HJ, Chung S, Park MK (2011) Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta. J Neurochem 116:966-74 [Journal] [PubMed]

Johnson SW (2008) Rebound bursts following inhibition: how dopamine modifies firing pattern in subthalamic neurons. J Physiol 586:2033 [Journal] [PubMed]

Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342:619-30 [Journal] [PubMed]

Jourdain VA, Schechtmann G, Di Paolo T (2014) Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action. J Neurosurg 120:140-51 [Journal] [PubMed]

Kang G, Lowery MM (2013) Interaction of oscillations, and their suppression via deep brain stimulation, in a model of the cortico-basal ganglia network. IEEE Trans Neural Syst Rehabil Eng 21:244-53 [Journal] [PubMed]

Kang G, Lowery MM (2014) Effects of antidromic and orthodromic activation of STN afferent axons during DBS in Parkinson's disease: a simulation study. Front Comput Neurosci 8:32 [Journal] [PubMed]

Kita H, Chang HT, Kitai ST (1983) The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis. J Comp Neurol 215:245-57 [Journal] [PubMed]

Kita H, Kita T (2011) Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats. Front Syst Neurosci 5:42 [Journal] [PubMed]

Kita H, Kitai ST (1987) Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol 260:435-52 [Journal] [PubMed]

Kita H, Kitai ST (1994) The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain Res 636:308-19 [PubMed]

Kreiss DS, Mastropietro CW, Rawji SS, Walters JR (1997) The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 17:6807-19

Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151-70 [PubMed]

Ledonne A, Mango D, Bernardi G, Berretta N, Mercuri NB (2012) A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro. Exp Neurol 233:292-302 [Journal] [PubMed]

Lee HH, Yang LL, Wang CC, Hu SY, Chang SF, Lee YH (2003) Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res 986:103-13 [PubMed]

Lee KH, Chang SY, Roberts DW, Kim U (2004) Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J Neurosurg 101:511-7 [Journal] [PubMed]

Lee KH,Duffy PS,Bieber AJ (2016) Deep Brain Stimulation: Indications and Applications

Liang CL, Nelson O, Yazdani U, Pasbakhsh P, German DC (2004) Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. J Comp Neurol 473:97-106 [Journal] [PubMed]

Lindahl M, Kamali Sarvestani I, Ekeberg O, Kotaleski JH (2013) Signal enhancement in the output stage of the basal ganglia by synaptic short-term plasticity in the direct, indirect, and hyperdirect pathways. Front Comput Neurosci 7:76 [Journal] [PubMed]

Lintas A, Silkis IG, Albéri L, Villa AE (2012) Dopamine deficiency increases synchronized activity in the rat subthalamic nucleus. Brain Res 1434:142-51 [Journal] [PubMed]

Litvak V, Jha A, Eusebio A, Oostenveld R, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P (2011) Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease. Brain 134:359-74 [Journal] [PubMed]

Lukasiewicz PD, Werblin FS (1990) The spatial distribution of excitatory and inhibitory inputs to ganglion cell dendrites in the tiger salamander retina. J Neurosci 10:210-21 [PubMed]

Maesawa S, Kaneoke Y, Kajita Y, Usui N, Misawa N, Nakayama A, Yoshida J (2004) Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg 100:679-87 [Journal] [PubMed]

Magill PJ, Bolam JP, Bevan MD (2001) Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106:313-30 [PubMed]

Mamad O, Delaville C, Benjelloun W, Benazzouz A (2015) Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons. PLoS One 10:e0119152 [Journal] [PubMed]

Mandali A, Chakravarthy VS (2016) Probing the Role of Medication, DBS Electrode Position, and Antidromic Activation on Impulsivity Using a Computational Model of Basal Ganglia. Front Hum Neurosci 10:450 [Journal] [PubMed]

Mandali A, Rengaswamy M, Chakravarthy VS, Moustafa AA (2015) A spiking Basal Ganglia model of synchrony, exploration and decision making. Front Neurosci 9:191 [Journal] [PubMed]

Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR, Wichmann T, Smith Y (2011) Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain 134:2057-73 [Journal] [PubMed]

McDougal RA, Morse TM, Carnevale T, Marenco L, Wang R, Migliore M, Miller PL, Shepherd GM, Hines ML (2017) Twenty years of ModelDB and beyond: building essential modeling tools for the future of neuroscience. J Comput Neurosci 42:1-10 [Journal] [PubMed]

McGeer PL, McGeer EG (2008) Glial reactions in Parkinson's disease. Mov Disord 23:474-83 [Journal] [PubMed]

McIntyre CC, Mori S, Sherman DL, Thakor NV, Vitek JL (2004) Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus. Clin Neurophysiol 115:589-95 [Journal] [PubMed]

Meissner W, Leblois A, Hansel D, Bioulac B, Gross CE, Benazzouz A, Boraud T (2005) Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 128:2372-82 [Journal] [PubMed]

Mena MA, García de Yébenes J (2008) Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia. Neuroscientist 14:544-60 [Journal] [PubMed]

Mergenthaler P, Lindauer U, Dienel GA, Meisel A (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 36:587-97 [Journal] [PubMed]

Merino M, Vizuete ML, Cano J, Machado A (1999) The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+. J Neurochem 73:750-7 [PubMed]

Michmizos KP, Nikita KS (2011) Addition of deep brain stimulation signal to a local field potential driven Izhikevich model masks the pathological firing pattern of an STN neuron. Conf Proc IEEE Eng Med Biol Soc 2011:7290-3 [Journal] [PubMed]

Modolo J, Mosekilde E, Beuter A (2007) New insights offered by a computational model of deep brain stimulation. J Physiol Paris 101:56-63 [Journal] [PubMed]

Montgomery EB, Gale JT (2008) Mechanisms of action of deep brain stimulation(DBS) . Neurosci Biobehav Rev 32:388-407 [Journal] [PubMed]

Moran A, Stein E, Tischler H, Bar-Gad I (2012) Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate. Neurobiol Dis 45:583-90 [Journal] [PubMed]

Moran A, Stein E, Tischler H, Belelovsky K, Bar-Gad I (2011) Dynamic stereotypic responses of Basal Ganglia neurons to subthalamic nucleus high-frequency stimulation in the parkinsonian primate. Front Syst Neurosci 5:21 [Journal] [PubMed]

Moro E, Esselink RJ, Xie J, Hommel M, Benabid AL, Pollak P (2002) The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology 59:706-13 [PubMed]

Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218-29 [Journal] [PubMed]

Muddapu VR,Chakravarthy SV (2017) Programmed cell death in substantia nigra due to subthalamic nucleus-mediated excitotoxicity: a computational model of Parkinsonian neurodegeneration BMC Neurosci. 18:59 [Journal]

Muddapu VR,Mandali A,Chakravarthy SV,Ramaswamy S (2018) A computational model of loss of dopaminergic cells in Parkinson's disease due to glutamate-induced excitotoxicity bioRXiv :1-69 [Journal]

Murray TK, Messenger MJ, Ward MA, Woodhouse S, Osborne DJ, Duty S, O'Neill MJ (2002) Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease. Pharmacol Biochem Behav 73:455-66 [PubMed]

Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ (2003) LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. J Pharmacol Exp Ther 306:752-62 [Journal] [PubMed]

Musacchio T, Rebenstorff M, Fluri F, Brotchie JM, Volkmann J, Koprich JB, Ip CW (2017) Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T a-synuclein Parkinson's disease rat model. Ann Neurol 81:825-836 [Journal] [PubMed]

O'Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P (2004) Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease. Eur J Pharmacol 486:163-74 [Journal] [PubMed]

Obeso I, Casabona E, Rodríguez-Rojas R, Bringas ML, Macías R, Pavón N, Obeso JA, Jahanshahi M (2017) Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changes. Cortex 94:39-48 [Journal] [PubMed]

Olanow CW, Jenner P, Brooks D (1998) Dopamine agonists and neuroprotection in Parkinson's disease. Ann Neurol 44:S167-74 [PubMed]

Oorschot DE (1996) Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol 366:580-99 [Journal] [PubMed]

Ortiz G. G., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Flores-Alvarado, LJ,González-Usigli H,Sánchez-López AL,et al (2016) Oxidative stress and Parkinson's disease: effects on environmental toxicology Free Radicals and Diseases, :183-209

Pacelli C, Giguère N, Bourque MJ, Lévesque M, Slack RS, Trudeau LÉ (2015) Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Curr Biol 25:2349-60 [Journal] [PubMed]

Park C, Worth RM, Rubchinsky LL (2010) Fine temporal structure of beta oscillations synchronization in subthalamic nucleus in Parkinson's disease. J Neurophysiol 103:2707-16 [Journal] [PubMed]

Park C, Worth RM, Rubchinsky LL (2011) Neural dynamics in parkinsonian brain: the boundary between synchronized and nonsynchronized dynamics. Phys Rev E Stat Nonlin Soft Matter Phys 83:042901 [Journal] [PubMed]

Park SE,Song K-i,Suh J-kF,Youn I (2015) Characteristics of the neuronal firing patterns in the subthalamic nucleus with graded dopaminergic cell loss in the nigrostriatal pathway Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference (Milan) :2510-2513

Paul G, Meissner W, Rein S, Harnack D, Winter C, Hosmann K, Morgenstern R, Kupsch A (2004) Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol 185:272-80 [PubMed]

Pavlides A, Hogan SJ, Bogacz R (2015) Computational Models Describing Possible Mechanisms for Generation of Excessive Beta Oscillations in Parkinson's Disease. PLoS Comput Biol 11:e1004609 [Journal] [PubMed]

   Excessive beta oscillations in Parkinson's disease (Pavlides et al. 2015) [Model]

Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH (1995) Differential expression of two vesicular monoamine transporters. J Neurosci 15:6179-88 [PubMed]

Philips RT, Chhabria K, Chakravarthy VS (2016) Vascular Dynamics Aid a Coupled Neurovascular Network Learn Sparse Independent Features: A Computational Model. Front Neural Circuits 10:7 [Journal] [PubMed]

Piallat B, Benazzouz A, Benabid AL (1996) Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci 8:1408-14 [PubMed]

Piccini P,Pavese N (2006) State-of-the-art Therapeutic Strategies in Parkinson's Disease Eur. Neurol. Rev. 6:20-25 [Journal]

Pinsky PF, Rinzel J (1995) Synchrony measures for biological neural networks. Biol Cybern 73:129-37 [PubMed]

Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease. Front Comput Neurosci 7:13 [Journal] [PubMed]

Reeve AK, Grady JP, Cosgrave EM, Bennison E, Chen C, Hepplewhite PD, Morris CM (2018) Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson's disease. NPJ Parkinsons Dis 4:9 [Journal] [PubMed]

Rite I, Machado A, Cano J, Venero JL (2007) Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J Neurochem 101:1567-82 [Journal] [PubMed]

Rocha SM, Cristovão AC, Campos FL, Fonseca CP, Baltazar G (2012) Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiol Dis 47:407-15 [Journal] [PubMed]

Rodriguez MC, Obeso JA, Olanow CW (1998) Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44:S175-88 [PubMed]

Rosenbaum R, Zimnik A, Zheng F, Turner RS, Alzheimer C, Doiron B, Rubin JE (2014) Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation. Neurobiol Dis 62:86-99 [Journal] [PubMed]

Rubin JE, Terman D (2004) High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model. J Comput Neurosci 16:211-35 [Journal] [PubMed]

   High frequency stimulation of the Subthalamic Nucleus (Rubin and Terman 2004) [Model]
   Optimal deep brain stimulation of the subthalamic nucleus-a computational study (Feng et al. 2007) [Model]

Schapira AH (2003) Neuroprotection in PD--a role for dopamine agonists? Neurology 61:S34-42 [PubMed]

Schapira AH, Olanow CW (2003) Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease. Ann Neurol 53 Suppl 3:S149-57; discussion S157-9 [Journal] [PubMed]

Seidl SE, Potashkin JA (2011) The promise of neuroprotective agents in Parkinson's disease. Front Neurol 2:68 [Journal] [PubMed]

Shen KZ, Johnson SW (2000) Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol 525 Pt 2:331-41 [PubMed]

Shen KZ, Johnson SW (2008) Complex EPSCs evoked in substantia nigra reticulata neurons are disrupted by repetitive stimulation of the subthalamic nucleus. Synapse 62:237-42 [Journal] [PubMed]

Shouno O, Tachibana Y, Nambu A, Doya K (2017) Computational Model of Recurrent Subthalamo-Pallidal Circuit for Generation of Parkinsonian Oscillations. Front Neuroanat 11:21 [Journal] [PubMed]

Smith ID, Grace AA (1992) Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12:287-303 [Journal] [PubMed]

Smith Y, Kieval JZ (2000) Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 23:S28-33 [PubMed]

Spieles-Engemann AL, Behbehani MM, Collier TJ, Wohlgenant SL, Steece-Collier K, Paumier K, Daley BF, Gombash S, Madhavan L, Mandybur GT, Lipton JW, Terpstra BT, Sortwell CE (2010) Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiol Dis 39:105-15 [Journal] [PubMed]

Stykel MG, Humphries K, Kirby MP, Czaniecki C, Wang T, Ryan T, Bamm V, Ryan SD (2018) Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease. FASEB J 32:5350-5364 [Journal] [PubMed]

Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci 30:244-50 [Journal] [PubMed]

Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson's disease. Mov Disord 28:41-50 [Journal] [PubMed]

Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA (2010) What causes the death of dopaminergic neurons in Parkinson's disease? Prog Brain Res 183:59-77 [Journal] [PubMed]

Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101-113 [Journal] [PubMed]

Temel Y, Visser-Vandewalle V, Kaplan S, Kozan R, Daemen MA, Blokland A, Schmitz C, Steinbusch HW (2006) Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Res 1120:100-5 [Journal] [PubMed]

Tepper JM, Lee CR (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160:189-208 [Journal] [PubMed]

Terman D, Rubin JE, Yew AC, Wilson CJ (2002) Activity patterns in a model for the subthalamopallidal network of the basal ganglia. J Neurosci 22:2963-76 [Journal] [PubMed]

   Optimal deep brain stimulation of the subthalamic nucleus-a computational study (Feng et al. 2007) [Model]
   Activity patterns in a subthalamopallidal network of the basal ganglia model (Terman et al 2002) [Model]

Tripathy SJ, Savitskaya J, Burton SD, Urban NN, Gerkin RC (2014) NeuroElectro: a window to the world's neuron electrophysiology data. Front Neuroinform 8:40 [Journal] [PubMed]

Tsai PI, Lin CH, Hsieh CH, Papakyrikos AM, Kim MJ, Napolioni V, Schoor C, Couthouis J, Wu RM, Wszolek ZK, Winter D, Greicius MD, Ross OA, Wang X (2018) PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions. Mol Cell 69:744-756.e6 [Journal] [PubMed]

Turski L, Bressler K, Rettig KJ, Löschmann PA, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349:414-8 [Journal] [PubMed]

Vaarmann A, Kovac S, Holmström KM, Gandhi S, Abramov AY (2013) Dopamine protects neurons against glutamate-induced excitotoxicity. Cell Death Dis 4:e455 [Journal] [PubMed]

Van_elburg RA, Van_ooyen A (2004) A new measure for bursting Neurocomputing Neurocomputing 58-60:497-502

Vandecasteele M, Glowinski J, Venance L (2005) Electrical synapses between dopaminergic neurons of the substantia nigra pars compacta. J Neurosci 25:291-8 [Journal] [PubMed]

Vernon AC, Palmer S, Datla KP, Zbarsky V, Croucher MJ, Dexter DT (2005) Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease. Eur J Neurosci 22:1799-806 [Journal] [PubMed]

Vila M, Périer C, Féger J, Yelnik J, Faucheux B, Ruberg M, Raisman-Vozari R, Agid Y, Hirsch EC (2000) Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur J Neurosci 12:337-44 [PubMed]

Waak J, Weber SS, Waldenmaier A, Görner K, Alunni-Fabbroni M, Schell H, Vogt-Weisenhorn D, Pham TT, Reumers V, Baekelandt V, Wurst W, Kahle PJ (2009) Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB J 23:2478-89 [Journal] [PubMed]

Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, Benabid AL (2007) Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 130:2129-45 [Journal] [PubMed]

Wang XJ, Rinzel J (1993) Spindle rhythmicity in the reticularis thalami nucleus: synchronization among mutually inhibitory neurons. Neuroscience 53:899-904 [PubMed]

Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M, Lang AE, Dostrovsky JO (2006) Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol 96:3248-56 [Journal] [PubMed]

Wellstead P (2010) Systems biology and the spirit of tustin IEEE Control Syst 30:57-102 [Journal]

Wellstead P, Cloutier M (2011) An energy systems approach to Parkinson's disease. Wiley Interdiscip Rev Syst Biol Med 3:1-6 [Journal] [PubMed]

Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 150:963-76 [Journal] [PubMed]

Wright AK, Arbuthnott GW (2007) The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats. Eur J Neurosci 26:642-8 [Journal] [PubMed]

Wright AK,McLaughlin KE,Atherton JF,Norrie L,Arbuthnott GW (2002) Lesions of the rat globus pallidus, which increase subthalamic nucleus activity, cause dopamine cell death The Basal Ganglia VII, Nicholson LFB:Faull RLM, ed. pp.457

Yang C, Yan Z, Zhao B, Wang J, Gao G, Zhu J, Wang W (2016) D2 dopamine receptors modulate neuronal resonance in subthalamic nucleus and cortical high-voltage spindles through HCN channels. Neuropharmacology 105:258-269 [Journal] [PubMed]

Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R (2008) Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Acta Neuropathol 116:47-55 [Journal] [PubMed]

Zhang J, Tan LC (2016) Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist. Curr Neuropharmacol 14:356-63 [PubMed]

Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A, Zucca FA, Faust R, Qian SY, Miller DS, Chignell CF, Wilson B, Jackson-Lewis V, Przedborski S, Joset D, Loike J, Hong JS, Sulzer D, Zecca L (2011) Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. Neurotox Res 19:63-72 [Journal] [PubMed]

Zheng F, Lammert K, Nixdorf-Bergweiler BE, Steigerwald F, Volkmann J, Alzheimer C (2011) Axonal failure during high frequency stimulation of rat subthalamic nucleus. J Physiol 589:2781-93 [Journal] [PubMed]

Zuddas A, Oberto G, Vaglini F, Fascetti F, Fornai F, Corsini GU (1992) MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J Neurochem 59:733-9 [PubMed]

Zuddas A, Vaglini F, Fornai F, Fascetti F, Saginario A, Corsini GU (1992) Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. Ann N Y Acad Sci 648:268-71 [PubMed]

(192 refs)